anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

129,121-129,180 of 319,975

filter-aware
01
Slide 1
This is a short-seller research note cover page/executive summary.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
02
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
03
The slide uses a 'villain' narrative technique by juxtaposing critical expert opinion with aggressive sales tactics and controversial industry associations.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
04
The slide uses a direct quote to frame the company's sales practices as unethical or problematic.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
05
The slide uses a testimonial to cast doubt on the company's reported metrics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
06
The slide uses highly aggressive, accusatory language to frame the report's sections.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
07
The slide uses a highly critical, investigative tone, framing the company as fraudulent and the drug as dangerous.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
08
The slide uses a narrative structure to frame the drug's history as a series of red flags and industry failures.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
09
The slide uses a list-based structure to present evidence of drug toxicity, citing specific page ranges from a larger document.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
10
The slide uses a structured list format to present three distinct areas of clinical concern, each with corresponding reference numbers.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
11
The slide uses a narrative-based evidence approach to build a case against the drug's safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
12
The slide uses a highly critical, investigative tone, framing the subject as a 'scam' and a 'failed launch'.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
13
The slide uses a 'villain critique' style to undermine the company's marketing claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
14
The slide uses strong, accusatory language ('disaster', 'fraud', 'kickback scheme', 'whales') to frame the company's business model as unsustainable and illegal.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
15
The slide uses a narrative structure to present evidence of corporate misconduct and operational failure.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
16
Uses historical precedent (Enron/Skilling and Insys) to frame current events at Harmony (HRMY) as a potential fraud or legal violation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
17
The slide uses a narrative of 'fraud' to frame the company's management and reporting practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
18
The slide uses a narrative of past professional failure and alleged fraud to undermine the credibility of the current CFO.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
19
The slide uses a narrative structure to expose potential accounting opacity and price-driven revenue growth.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
20
The slide uses a direct quote from an earnings call to highlight a lack of transparency and potential business risk.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
21
The slide uses EMA data to contradict the limited disclosure in the primary trial paper.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
22
The slide uses highlighted quotes to emphasize the lack of data transparency and the high patient drop-off rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
23
The slide uses direct quotes from an expert consultation to build a case for potential fraud or misrepresentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
24
The slide uses a Q&A format to present qualitative evidence of corporate malfeasance or short-termism.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
25
The slide uses highly critical, adversarial language ('toxic drug', 'face-planted', 'questionable French lab') to frame the company negatively.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
26
The slide uses a combination of narrative argument and a supporting table of pharmacologic approaches to justify the 'difficult' commercial landscape.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
27
The slide uses a comparative analysis of pricing and regulatory status to undermine the competitor's market position.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
28
The slide uses direct quotes from medical professionals to undermine the competitive advantage of the subject drug (Wakix).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
29
The slide uses a scientific diagram to explain the mechanism while simultaneously casting doubt on the underlying theory.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
30
The slide uses a 'villain' narrative style to attack the legitimacy of Harmony Biosciences' IP.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
31
The slide argues that the patent claims are spurious because the inventors are the same as those who published the molecule in 2002, and PubChem shows prior art from 2006.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
32
The slide uses a narrative of past professional failure to cast doubt on current leadership.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
33
The slide uses a 'before-after' style comparison of a website vs. an empty search result to discredit the subject.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
34
The slide uses a WSJ article as a source to expose the CEO's attempt to distance himself from a controversial business practice.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
35
The slide uses a narrative of past misconduct to establish a pattern of behavior for the subject.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
36
The slide uses visual evidence (empty chair, press conference) to frame the subject as a villain in a political/regulatory context.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
37
The slide uses a narrative structure to link a specific company's strategy to a broader pattern of behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
38
The slide uses a combination of summary text and a direct testimonial quote to establish a pattern of behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
39
The slide uses a 'short' thesis argument to frame scientific data as fraudulent.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
40
The slide uses a testimonial quote to support a narrative of corporate malfeasance and trial data manipulation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
41
The slide uses a Q&A format to highlight potential corporate malfeasance regarding clinical trial adverse events.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
42
The slide uses highlighted text to emphasize key admissions regarding management's role in stopping the study.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
43
The slide uses a Q&A format to present qualitative evidence of internal doubt regarding clinical trial integrity.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
44
The slide uses direct quotes from a neurologist to cast doubt on Bioprojet's professionalism and data management.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
45
The slide uses a bar chart to visualize payment data from CMS OpenPayments to support a narrative of questionable marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
169
This slide is part of a short-seller activist report.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
170
The slide uses red borders to emphasize the co-founders, contrasting them with the CEO and CFO.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
171
Uses LinkedIn profile screenshots to highlight conflicting or dual-employment status.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
172
The slide uses a 'villain' framing by questioning the capacity of the subject to fulfill all stated obligations.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
173
The slide uses highlighted text to emphasize key claims about the co-founders' behavior and lack of presence.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
174
The slide uses Q&A transcripts to build a narrative of leadership negligence and physical absence.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
175
The slide uses direct quotes from industry experts to undermine the credibility of the company's leadership structure.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
176
The slide uses a highlight to emphasize the core contradiction in the quote.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
177
The slide uses direct quotes and Q&A transcripts to build a narrative of executive negligence.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
178
This is a direct attack on the CEO's personal integrity and background.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
179
The slide uses screenshots of LinkedIn and interview transcripts to support the claim of a manufactured persona.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
180
The slide uses red circles and arrows to highlight the specific fields in the LinkedIn UI that require manual input, contrasting them with the subject's profile display.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
181
The slide uses visual callouts (red circles and arrows) to point out the specific text segments being compared.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
182
This is an activist short-seller deck slide attacking the credibility of a CEO.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
183
Uses Q&A format to highlight lack of transparency regarding a key executive.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit